ABOUT US
Drug Discovery and Development Consultants was founded in 2018 with the objective of addressing a need in the market through offering a consultancy service providing support and advice across all aspects of drug discovery and development. As a team, we benefit from the advantage of having worked together for many years thus providing obvious efficiencies in ensuring cost-effective and timely delivery of our client’s objectives. We also benefit from access to an extended network of both industry and academia-based associates as befits our longevity in the industry. Our collective experience includes:
Discovery and implementation of new technologies
Drug target identification
Drug discovery activities through hit ID, LG, LO and drug candidate nomination
Non-clinical development campaigns including pharmacology, drug metabolism and pharmacokinetics (DMPK), drug candidate scale-up, CMC, exploratory and GLP tox
Programme leadership/management/budget preparation/project planning
Executing programmes as a virtual team from discovery to Phase 1 first time in human and Phase 2 POC
Clinical Operations expertise in Phase 1 clinical studies including First in Human and Phase 2 POC
Establishing and maintaining Quality Management Systems
Regulatory and QA advice
In-licensing and out-licensing activities including due diligence on companies as well as assets
Working in partnerships with big pharma, biotechs and CROs
Company start-ups and sales
THE TEAM
ASSOCIATES
Medicinal Chemistry and CMC
MIKE HIGGINBOTTOM
